Results 171 to 180 of about 16,580 (182)
Some of the next articles are maybe not open access.
Oncogene, 1996
The growth suppressing activity of the retinoblastoma suspectibility gene product, pRb, is down regulated by cyclin-dependent kinases 4 and 6 (CDK4 and CDK6) whose kinase activity is negatively regulated by CDK inhibitors of the p16 family. We have examined the genomic status of two recently isolated p16-related CDK inhibitors, p15 and p18, in 15 ...
M, Zariwala, E, Liu, Y, Xiong
openaire +1 more source
The growth suppressing activity of the retinoblastoma suspectibility gene product, pRb, is down regulated by cyclin-dependent kinases 4 and 6 (CDK4 and CDK6) whose kinase activity is negatively regulated by CDK inhibitors of the p16 family. We have examined the genomic status of two recently isolated p16-related CDK inhibitors, p15 and p18, in 15 ...
M, Zariwala, E, Liu, Y, Xiong
openaire +1 more source
Cyclin-dependent kinase (cdk6) and p16 in pancreatic endocrine neoplasms
Pathology, 2004Tatsuo Tomita
exaly
Regulation of cyclin dependent kinase inhibitor proteins during neonatal cerebella development
Developmental Brain Research, 1998Genichi Watanabe +2 more
exaly
The cyclin-dependent kinase inhibitor p21 is required for TGF-β1-induced podocyte apoptosis
Kidney International, 2005Jeffrey W Pippin, Stuart J Shankland
exaly
Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status
Expert Opinion on Investigational Drugs, 2000Lloyd R Kelland, L R Kelland
exaly

